UBS raises price target on Nvidia ahead of earnings, says tailwinds ‘remain strong’

UBS has increased its price target for Nvidia to $205 from $175, reiterating a buy rating ahead of next week's Q2 earnings, driven by strong demand signals, including significant data center load requests and anticipated GB200/GB300 rack deployments. Analyst Timothy Arcuri expects a ~$1 billion Q2 revenue beat, further bolstered by potential revenue from the H20 chip deal for China. This bullish outlook, shared by most analysts, comes as NVDA shares have already surged over 30% year-to-date.

Analysis

UBS has reaffirmed its bullish stance on Nvidia, raising its price target to $205 from $175, which implies an approximate 17% upside from its recent closing price. This outlook is anchored in exceptionally strong demand signals for AI infrastructure, highlighted by an analyst observation of approximately 40GW in new data center load requests in Texas alone. While acknowledging the potential for some double-ordering, the core expectation is for a powerful demand backdrop to be reflected in Nvidia's upcoming Q2 report. Further fueling this optimism are indications from rack partners that deploying 30,000 GB200/GB300 racks is feasible this year, signaling a significant ramp in the fourth quarter. A secondary, yet material, catalyst is the company's agreement with the U.S. government to resume chip sales to China with the H20 model, which is projected to add several billion dollars in quarterly revenue. The analyst anticipates a Q2 revenue beat of around $1 billion, a view that aligns with a broader Wall Street consensus where 58 out of 65 analysts hold a buy or strong buy rating. This positive sentiment exists in the context of the stock already gaining over 30% year-to-date, setting high expectations for the upcoming earnings announcement.

Key Decisions for Investors

• The strong analyst consensus and specific demand indicators for new data center capacity and GB200/GB300 racks reinforce a bullish outlook, positioning the upcoming earnings report as a key validation event for the stock's recent rally.
• Investors should closely monitor the stability of the H20 chip sales agreement for China, as this new revenue stream is subject to geopolitical risk and any changes in U.S. export control policy could materially affect guidance.
• Given the stock's over 30% year-to-date gain, investors should be mindful of the high expectations already priced in, as any shortfall relative to the anticipated ~$1 billion revenue beat or a weaker-than-expected outlook could expose the position to downside risk.